Novo Nordisk: 2024 Earnings Review
Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...
Transcript of ‘60 Minutes’ Interview With Kamala Harris
The Federal Communications Commission on Wednesday released the transcript of a “60 Minutes” interview with Vice President Kamala Harris that has been at the center of a lawsuit between CBS and ...
Hosted on MSN6d
Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock?
Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...
What, exactly, is wrong with the fireproofing in the new Sherwin Williams Cleveland tower? Today in Ohio
Williams is facing issues with its own fire-retardant product in its new downtown headquarters. We’re talking about what’s wrong with the building — and what the company isn’t saying — on Today in ...
Insulin prices are falling due to market forces — no price caps required
If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...
Twin Cities Business6d
Minnesota AG Reaches Another Insulin Price Cap Settlement
Keith Ellison said he's reached a deal with Danish pharmaceutical company Novo Nordisk to keep the cost of insulin at $35 a ...
Some in the Ozarks struggling to pay for insulin despite lower drug prices
“Insulin used to cost around $500 for one box, and now it’s down to somewhere around $150, $200, so they’ve really dropped ...
Drug Store News2d
Novo Nordisk to cap insulin prices in Minnesota settlement
The settlement filed in Newark, N.J. federal court comes after similar settlements with Eli Lilly and Sanofi last year. It ...